首页> 外文期刊>Journal of Surgical Oncology >Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.
【24h】

Modified radical lymphadenectomy without splenectomy in patients with proximal gastric cancer: comparison with standard D2 lymphadenectomy for distal gastric cancer.

机译:改良的不进行脾切除的根治性淋巴结清扫术:与远端胃癌的标准D2淋巴结清扫术比较。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVES: We assessed the optimal extent of lymph node dissection and the effect of splenectomy in patients with proximal gastric cancer. METHOD: Recurrence and survival rates were compared between 881 patients with proximal gastric cancer who underwent modified radical lymphadenectomy and 3,098 patients with distal gastric cancer who underwent standard D2 lymphadenectomy. RESULTS: The recurrence rate was significantly higher in the total than in the distal gastrectomy group (32.5% vs. 16.5%, P < 0.001), but the rates were similar after adjustment for TNM stage. The overall 5-year survival rate was significantly higher in the distal than in the total gastrectomy group (80.4% vs. 66.2%, P < 0.001), but this difference was not observed after adjustment for TNM stage. Multivariate analysis showed that patient age, number of retrieved lymph nodes, depth of invasion, and nodal metastasis were independent prognostic determinants for survival, whereas type of lymphadenectomy was not. CONCLUSION: Long-term outcomes were similar in patients with proximal gastric cancer who underwent modified lymphadenectomy without splenectomy and in patients with distal gastric cancer who underwent standard D2 lymphadenectomy. These findings indicate that modified radical lymphadenectomy without splenectomy is sufficient for optimal lymph node dissection in patients with proximal gastric cancer.
机译:背景与目的:我们评估了近端胃癌患者淋巴结清扫的最佳范围和脾切除的效果。方法:比较881例接受改良根治性淋巴结清扫术的近端胃癌患者和3,098例接受标准D2淋巴结清扫术的远端胃癌患者的复发和生存率。结果:总复发率显着高于远端胃切除术组(32.5%vs. 16.5%,P <0.001),但经TNM分期调整后,复发率相似。远端总的5年生存率显着高于总胃切除术组(80.4%vs. 66.2%,P <0.001),但在TNM分期调整后未观察到这种差异。多因素分析表明,患者的年龄,淋巴结的回收数目,浸润深度和淋巴结转移是生存的独立预后因素,而淋巴结清扫术的类型则不是。结论:接受改良脾淋巴结清扫术但不行脾切除术的近端胃癌患者和接受标准D2淋巴结清扫术的远端胃癌患者的长期预后相似。这些发现表明,不进行脾切除术的改良根治性淋巴结清扫术足以使近端胃癌患者实现最佳的淋巴结清扫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号